CTMX
Price
$2.04Alerts
Change
-$0.09 (-4.23%)
Updated
Nov 12 closing price
Capitalization
477.2M
103 days until earnings call
Intraday BUY SELL Signals
SILO
Price
$1.91Alerts
Change
+$0.05 (+2.69%)
Updated
Nov 12 closing price
Capitalization
2.28M
Intraday BUY SELL Signals
Interact to see
Advertisement

CTMX vs SILO

CTMX vs SILO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CTMX vs. SILO commentary
Nov 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Hold and SILO is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CTMX with price predictions
Nov 12, 2026

CTMX's Stochastic Oscillator is remaining in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CTMX's RSI Oscillator exited the oversold zone, 35 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

Following a +6.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTMX advanced for three days, in 182 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

CTMX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTMX as a result. In 79 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for CTMX turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 39 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTMX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for CTMX entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.580) is normal, around the industry mean (3.498). P/E Ratio (-3.842) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (27.624) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. CTMX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTMX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for SILO with price predictions
Nov 12, 2026

SILO in upward trend: price rose above 50-day moving average on November 09, 2026

SILO moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 47 of 53 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on SILO as a result. In 88 of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

Following a +6.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where SILO advanced for three days, in 213 of 247 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 75 of 86 cases where SILO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SILO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

SILO broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. SILO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.466) is normal, around the industry mean (3.498). P/E Ratio (-0.348) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (3.910) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (28.736) is also within normal values, averaging (440.869).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SILO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
CTMX vs SILO: Fundamental Ratings
CTMX
SILO
OUTLOOK RATING
1..100
526
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
8165
P/E GROWTH RATING
1..100
987
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTMX's Valuation (27) in the Biotechnology industry is somewhat better than the same rating for SILO (82) in the null industry. This means that CTMX’s stock grew somewhat faster than SILO’s over the last 12 months.

CTMX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SILO (100) in the null industry. This means that CTMX’s stock grew similarly to SILO’s over the last 12 months.

CTMX's SMR Rating (97) in the Biotechnology industry is in the same range as SILO (98) in the null industry. This means that CTMX’s stock grew similarly to SILO’s over the last 12 months.

SILO's Price Growth Rating (65) in the null industry is in the same range as CTMX (81) in the Biotechnology industry. This means that SILO’s stock grew similarly to CTMX’s over the last 12 months.

SILO's P/E Growth Rating (7) in the null industry is significantly better than the same rating for CTMX (98) in the Biotechnology industry. This means that SILO’s stock grew significantly faster than CTMX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTMXSILO
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 16 days ago
77%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
COMPARISON
Comparison
Nov 13, 2026
Stock price -- (CTMX: $2.04 vs. SILO: $1.91)
Brand notoriety: CTMX and SILO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 64% vs. SILO: 168%
Market capitalization -- CTMX: $477.2M vs. SILO: $2.28M
CTMX [@Biotechnology] is valued at $477.2M. SILO’s [@Biotechnology] market capitalization is $2.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 1 FA rating(s) are green while SILO’s FA Score has 1 green FA rating(s).

  • CTMX’s FA Score: 1 green, 4 red.
  • SILO’s FA Score: 1 green, 4 red.
According to our system of comparison, SILO is a better buy in the long-term than CTMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 4 TA indicator(s) are bullish while SILO’s TA Score has 4 bullish TA indicator(s).

  • CTMX’s TA Score: 4 bullish, 4 bearish.
  • SILO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CTMX and SILO are a good buy in the short-term.

Price Growth

CTMX (@Biotechnology) experienced а -4.67% price change this week, while SILO (@Biotechnology) price change was +48.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.04%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -16.99%.

Reported Earning Dates

CTMX is expected to report earnings on Feb 24, 2027.

Industries' Descriptions

@Biotechnology (+2.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.